In the BRAFV600E‐positive COLO205 colorectal cancer cell line, the combination of MEK1/2 inhibitor with ABT‐263 strongly induced the expression of BIM and BMF and BIM knockdown reduced apoptosis by 50–70% 60. Here, BCL2L11 is linked to colorectal cancer.